Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Andrew Foy"'
Autor:
Jonathan Norton, Andrew Foy, Djibril M. Ba, Guodong Liu, Doug Leslie, Yue Zhang, Gerald V. Naccarelli
Publikováno v:
American Heart Journal Plus, Vol 40, Iss , Pp 100375- (2024)
Obesity significantly increases the risk of developing atrial fibrillation (AF) and atrial flutter (AFL) and evidence from randomized trials indicates that weight loss may reduce the burden of AF/AFL in obese patients; however, the relationship betwe
Externí odkaz:
https://doaj.org/article/77f5f937b3814d7ebc2f92dd48f5c1c5
Autor:
Mark T. Dransfield, Kelly Qi Jia, Mohammed Ruzieh, Emily S Edwards, Lama Al Jebbawi, Aaron D Baugh, Andrew Foy
Publikováno v:
Trends in Cardiovascular Medicine. 33:53-61
Beta-blockers (βB) are a frequently used class of medications. Although βB have many indications, those related to cardiovascular disease are among the most common and important. However, in patients with chronic obstructive pulmonary disease (COPD
Autor:
Katherine Carlton, Samuel Adams, Elizabeth Fischer, Andrew Foy, Amy Heffelfinger, Jenna Jozwik, Irene Kim, Jennifer Koop, Lauren Miller, Stacy Stibb, Susan Cohen
Publikováno v:
American Journal of Perinatology.
Objective The natural extension of inpatient-focused neonatal neurocritical care (NNCC) programs is the evaluation of long-term neurodevelopmental outcomes in the same patient population. Clinical Design A dedicated and collaborative team of neonatol
Publikováno v:
The American Journal of Cardiology. 164:44-51
The optimal timing of coronary artery bypass grafting (CABG) in patients after an acute myocardial infarction (MI) is unknown. We performed a systematic review and meta-analysis of studies comparing mortality rates in patients who underwent CABG at d
Autor:
Mohammed Ruzieh, Rita F. Redberg, Andrew Foy, Brandon Peterson, John Mandrola, Adam Sturts, Sanket S. Dhruva, Guodong Liu
Publikováno v:
The American Journal of Cardiology. 163:8-12
This study aimed to assess long-term resource utilization and outcomes in patients with acute chest pain who underwent coronary computed tomography angiography (CCTA) and stress echocardiography (SE). This was a retrospective, propensity-matched anal
Publikováno v:
The American Journal of Cardiology. 154:48-53
Evidence suggests glucagon-like peptide-1 receptor agonists (GLP-1 RA) reduce cardiovascular disease (CVD) events. The objective of this study was to analyze randomized controlled trials (RCT) testing GLP-1 RA's effect on CVD events among participant
Publikováno v:
Open access emergency medicine : OAEM. 14
Ravindra Gopaul,1 Robert A Waller,1 Ricci Kalayanamitra,2 Garrett Rucker,3 Andrew Foy4 1Department of Emergency Medicine, Penn State Hershey Medical Center, Hershey, PA, USA; 2Department of Emergency Medicine, Staten Island University Hospital, New Y
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 26:328-334
There are limited data from randomized controlled trials comparing rate control agents in atrial fibrillation. Patient-level data from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial was used to compare outcomes in
Publikováno v:
Journal of the American College of Cardiology. 78:153-155
Autor:
Erik Lehman, Michael J. Green, Andrew Foy, Debra L. Wiegand, Elizabeth Thiede, In Seo La, Daniella Lipnick, Lauren Jodi Van Scoy, John W. Creswell, Anne E.F. Dimmock, Benjamin H. Levi, Rhonda Johnson, Vernon M. Chinchilli
Publikováno v:
Journal of Mixed Methods Research. 15:567-586
The use of mixed methods research in intervention trials mostly centers around using quantitative data to assess primary outcomes and qualitative data primarily for exploratory purposes, to supplement, and/or explain quantitative findings. We describ